Adverum Biotechnologies
ADVM
ADVM
75 hedge funds and large institutions have $36.5M invested in Adverum Biotechnologies in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $28K
Holders
75
Holding in Top 10
–
Calls
–
Puts
$28K
Top Buyers
| 1 | +$3.78M | |
| 2 | +$1.13M | |
| 3 | +$540K | |
| 4 |
Renaissance Technologies
New York
|
+$465K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$390K |
Top Sellers
| 1 | -$2.53M | |
| 2 | -$485K | |
| 3 | -$485K | |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$398K |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$377K |